New targets for cancer chemotherapy.
Murgo
Anthony J
AJ
Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Blvd., Rockville, MD 20852, USA. murgoa@ctep.nci.nih.gov
Dancey
Janet
J
Eckhardt
S Gail
SG
Hidalgo
Manuel
M
Arbuck
Susan G
SG
Zerivitz
Kenn
K
Blaylock
Barbara A
BA
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002986:Clinical Trials as Topic; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction / Q000187:drug effects; D019098:Telomerase / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D019098:Telomerase